Heart, Lung and Circulation
Volume 15, Issue 3 , Pages 172-181 , June 2006

Pre-operative Preparation for Cardiac Surgery Utilising a Combination of Metabolic, Physical and Mental Therapy

Received 17 February 2005 ,Revised 11 January 2006 ,Accepted 19 January 2006.

References 

  1. Reid C, Dauern P, Dinh S, Birrell B, et al. ASCTS cardiac surgery database report 2003–2004. p. 51.
  2. Hadj A, Pepe S, Marasco S, Rosenfedlt F. The principles of metabolic therapy. Heart Lung Circ. 2003;12(S):55–62
  3. Burke B, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94(11):1112–1117
  4. Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Astrom H. CoQ10 as an adjunctive in the treatment of chronic congestive heart failure. J Card Fail. 1995;1(2):101–107
  5. Newman MAJ, Chen X-Z, Rabinov M, Williams JF, Rosenfeldt FL. Sensitivity of the recently infarcted heart to cardioplegia arrest. J Thorac Cardiovasc Surg. 1989;97:593–604
  6. Hagen TM, et al. Mitochondrial delay in the aging rat heart. Evidence for improvement by dietary Supplementation with acetyl-l-carnitine and/or lipoic acid. Ann N Y Acad Sci. 2002;959:491–507
  7. Pepe S, McLennan Pl. Cardiac membrane fatty acid composition modulates MVO2 and postischemic recovery of contractile function. Circulation. 2002;105:2303–2308
  8. Blomqvist CG. Cardiovascular adaptations to physical training. Annu Rev Physiol. 1983;45:168–169
  9. Astrand PO, Rodahl K. Textbook of work physiology: physiology bases of exercise. New York: McGraw-Hill Book Co; 1986;
  10. Rosenfeldt F, Marasco S, Lyon W, Wowk M, et al. Improved outcomes in cardiac surgery after pre-operative coenzyme Q10 therapy. J Thorac Cardiovasc Surg. 2005;129:25–32
  11. Myles P, et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects. Myocardial ischaemia and recovery. Anaesth Intensive Care. 1999;27:137–147
  12. OXIS Health Products International, Portland, OR, USA. Colometric assay for lipid perioxidation.
  13. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  14. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med. 1997;18(Suppl.):s159–s168
  15. Hiasa Y, Ishida T, Maeda T, Iwanc K, Aihara T, Mori H. Effects of CoQ10 on exercise tolerance in patients with stable angina pectoris. In:  Folkers K,  Yamamura Y editor. Biochemical and clinical aspects of CoQ10. Amsterdam: Elsevier; 1984;p. 291–301
  16. Wilson MF, Frishman WH, Giles T, Sethi G, Greenberg S, Brackett J. CoQ10 therapy and exercise duration in stable angina. In:  Folkers K,  Littaru GP,  Yamagami T editor. Biomedical and clinical aspects of CoQ10. Amsterdam: Elsevier; 1991;p. 339–348
  17. Chello M, et al. Protection by CoQ10 of tissue reperfusion injury during abdominal aortic cross-clamping. J Cardiovasc Surg. 1996;37(3):229–235
  18. Rosenfeldt F, et al. The effects on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology. 2002;3:37–40
  19. Crestanello JA, et al. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion. J Surg Res. 2002;102(2):221–228
  20. Rowland M, Nagley P, Linnane A, Rosenfeldt F. Coenzyme Q10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat. Cardiovasc Res. 1998;40:165–173
  21. Packer L. The antioxidant miracle. John Wiley & Sons; 1999;
  22. Richards S, Conyers R, Fisher J, Rosenfeldt F. Cardioprotection by orotic acid: metabolism and mechanism of action. J Mol Cell Cardiol. 1997;29(12):3239–3250
  23. Munsch C, Williams JF, Rosenfeldt FL. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: the protective effect of orotic acid. J Mol Cell Cardiol. 1989;21:751–754
  24. Han D, Handelman G, Marcocci L, et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors. 1997;6(3):321–338
  25. Haramaki N, et al. Cystolic and mitochondrial systems for NADH and NADPH-dependant reduction of alpha-lipoic acid. Free Radic Res. 1997;22:535–542
  26. Suh JH, et al. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J. 2001;15(3):700–706
  27. Kingwell B, Waddell T, Medley T, Cameron J, Dart A. Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol. 2002;40(4):773–779
  28. Vericel V, et al. The influence of low intake omega-3 fatty acids on platelets in elderly people. Atherosclerosis. 1999;147:187–192
  29. Hornstra G. Omega-3 and health benefits. France: Roche Vitamins; 2001;
  30. Gerster H. Fish oil (n−3 long-chain PUFAs) and blood pressure. Nutrition. 1993;17:15–24
  31. James M, et al. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71:343s–348s
  32. Grynberg A, Demaison LJ. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol. 1996;28(Suppl. 1):S11–S17
  33. Loscalzo J. Oxidative stress in endothelial cell dysfunction and thrombosis. Pathophysiol Haemost Thromb. 2002;32:359–360
  34. Clausen JP. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary heart disease. Prog Cardiovasc Dis. 1976;18:459–495
  35. Scheuer T. Cardiovascular adaptations to physical training. Annu Rev Physiol. 1983;45:169–189
  36. Shabetai R. Beneficial effects of exercise training in compensated heart failure. Circulation. 1988;78:775–776
  37. Tofler GH, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990;66:22–27
  38. Arthur H, et al. Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass surgery. A randomised controlled trial. Ann Intern Med. 2000;133:253–262
  39. Hambrecht R, Fiehn E, Weigal C, Gielen S, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation. 1998;98(24):2709–2715
  40. Muller JE, Abela G, Nesto R, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol. 1994;23:809–813
  41. Williams RB. Psychological factors in coronary heart disease: epidemiologic evidence. Circulation. 1987;76(1 Pt 2):I117–I123
  42. Blumenthal JA, Emery CF. Rehabilitation of patients following myocardial infarction. J Consult Clin Psychol. 1988;56:374–381
  43. Linden W, Stossel C, Maurice J. Psychological interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med. 1996;156:745–752
  44. Shiely JC, et al. SF-36 health survey annotated bibliography: the first edition (1988–1995). Boston, MA: The Health Institute, New England Medical Center; 1996;

PII: S1443-9506(06)00034-5

doi: 10.1016/j.hlc.2006.01.008

Heart, Lung and Circulation
Volume 15, Issue 3 , Pages 172-181 , June 2006

Article Tools

* Image Usage & Resolution